Stage FocusSeed, Series A, Series B+
GeographyUS, Europe
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Versant Ventures was founded in 1999 and manages $5.3B in AUM, making it one of the most successful life sciences VCs globally. The most recent raise totaled $950M across three vehicles — $560M for company formation, $140M for co-investment, and $250M for growth.
The portfolio spans 190 companies with 95+ acquisitions and IPOs. What distinguishes Versant is its "Discovery Engines" — in-house scie...
Notable Investments
A
Audentes TherapeuticsC
Crinetics PharmaceuticalsA
AtrecaSimilar Funds
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A
Bold Capital Partners
Santa Monica, United States
Pure DeepTechBiotechAI InfrastructureMedTechSeedSeries A
Brandon Capital
Melbourne, Australia
DeepTech NativeBiotechMedTechSeedSeries A
Cambridge Innovation Capital
Cambridge, United Kingdom
Pure DeepTechBiotechQuantum ComputingSemiconductorsSeedSeries A
Forbion
Naarden, Netherlands
Pure DeepTechBiotechSeedSeries A
Leaps by Bayer
Leverkusen, Germany
DeepTech NativeBiotechAgriTechMedTechSeedSeries A